Survival Effect of Neoadjuvant Radiotherapy Before Esophagectomy for Patients With Esophageal Cancer: A Surveillance, Epidemiology, and End-Results Study

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 2, 2009, Pages 449-455

  Schwer, Amanda L ^a   Ballonoff, Ari ^a   McCammon, Robert ^a   Rusthoven, Kyle ^a   D'Agostino Jr , Ralph B ^b   Schefter, Tracey E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Esophageal cancer; Neoadjuvant radiotherapy

Indexed keywords

COMPUTER OPERATING SYSTEMS; DATABASE SYSTEMS; DECISION MAKING; PATIENT MONITORING; RADIOTHERAPY; SURGERY;

COVARIATES; ESOPHAGEAL CANCER; ESOPHAGECTOMY; MULTIVARIATE ANALYSES; NEOADJUVANT RADIOTHERAPY; NODAL STATUSES; NUMBER OF NODES; OS RATES; OVERALL SURVIVALS; PROPORTIONAL HAZARDS; PROSPECTIVE STUDIES; SQUAMOUS CELL CARCINOMATA; SURVIVAL CURVES; UNIVARIATE;

MULTIVARIANT ANALYSIS;

ADENOCARCINOMA; ADJUVANT THERAPY; ARTICLE; CANCER EPIDEMIOLOGY; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NEOADJUVANT RADIOTHERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 58149343977     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.022     Document Type: Article

References (46)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Moertel C.G. Carcinoma of the esophagus: Is there a role for surgery? The case against surgery. Am J Dig Dis 23 (1978) 735-736
3. Mariette C., Piessen G., and Triboulet J.P. Therapeutic strategies in oesophageal carcinoma: Role of surgery and other modalities. Lancet 8 (2007) 545-553
4. Geh J.L., Crellin A.M., and Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 88 (2001) 338-356
5. Kavanagh B., Ancher M., Leopold K., et al. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys 24 (1992) 633-642
6. Poplin E., Fleming T., Leichman L., et al. Combined therapies for squamous cell carcinoma of the esophagus, a Southwest Oncology Group study (SWOG-8037). J Clin Oncol 5 (1990) 622-628
7. Forastiere A.A., Orringer M.B., Perez-Tamayo C., et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 11 (1993) 1118-1123
8. Stewart J.R., Hoff S.J., Johnson D.H., et al. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 218 (1993) 571-576
9. Fink U., Stein H.J., Bochtler J., et al. Neoadjuvant therapy for squamous cell esophageal carcinoma. Ann Oncol 5 Suppl. 3 (1994) 17-26
10. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
11. Urba S.G., Orringer M.B., Turrissi A., et al. Randomized study of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
12. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multi-modality therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
13. Le Prise E., Etienne P.L., Meunier B., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73 (1994) 1779-1784
14. Nygaard K., Hagen S., Hansen H.S., et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16 (1992) 1104-1110
15. Apinop C., Puttisak P., and Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41 (1994) 391-393
16. Law S., Kwong D.L.W., Tung H.M., et al. Preoperative chemoradiation for squamous cell esophageal cancer: A prospective randomized trial. [Abstract]. Can J Gastroenterol 12 Suppl. B (1998) 1008
17. Burmeister B.H., Smithers B.M., Fitzgerald L., et al. A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus. [Abstract]. Prog Proc Am Soc Clin Oncol 21 (2002) 130a
18. Arnott S.J., Duncan W., Gignoux M., et al. Preoperative radiotherapy in esophageal carcinoma: A meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 41 (1998) 579-583
19. Fiorica F., DiBona D., Schepis F., et al. Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis. Gut 53 (2004) 925-930
20. Urschel J.D., and Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185 (2003) 538-543
21. Kaklamanos I.G., Walker G.R., Ferry K., et al. Neoadjuvant treatment for resectable cancer of the esophagus and gastroesophageal junction: A meta-analysis of randomized clinical trials. Ann Surg Oncol 10 (2003) 754-761
22. Gebski V., Burmeister B., Smithers B.M., et al. Survival benefits from neoadjuvant chemoradiotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 8 (2007) 226-234
23. Suntharalingam M., Moughan J., Coia L.R., et al. The national practice for patients receiving radiation therapy for carcinoma of the esophagus: Results of the 1996-1999 patterns of care study. Int J Radiat Oncol Biol Phys 56 (2003) 981-987
24. Surveillance, Epidemiology and End-Results program Web site. Information about, 1/08. Available from: http://seer.cancer.gov/about. Accessed January 19, 2008.
25. Hankey B.F., Ries L.A., and Edwards B.K. The Surveillance, Epidemiology and End-Results program: A national resource. Cancer Epidemiol Biomarkers Prev 8 (1999) 1117-1121
26. Harlan L.C., and Hankey B.F. The Surveillance, Epidemiology and End-Results program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol 21 (2003) 2232-2233
27. Surveillance, Epidemiology and End-Results program Web site. Available from: http://seer.cancer.gov/data/access.html. Accessed January 19, 2008.
28. Virnig B.A., Warren J.L., Cooper G.S., et al. Studying radiation therapy using SEER-Medicare-lined data. Med Care 40 Suppl. 4 (2002) 49-54
29. *Stat software, version 6.3.5. Available from: seer.cancer.gov/seerstat. Accessed January 15, 2008.
30. Fritz A, Ries C. SEER extent of disease-1988 codes and coding instructions, third edition, 1/08. Available from: http://seer.cancer.gov/manuals/EOD10Dig.3rd.pdf. Accessed January 15, 2008.
31. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging handbook. 6th ed. (2002), Springer, New York
32. Surveillance, Epidemiology and End-Results program Web site. Available from: http://seer.cancer.gov/manuals/2007/SPCSM_2007_AppendixC_p2.pdf. Accessed January 15, 2008.
33. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-458
34. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
35. Cox D.R. Regression models and life-tables. JR Stat Soc [B] 34 (1972) 187-202
36. Lerut T., DeLeyn P., Coosemans W., et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 218 (1993) 213-214
37. Daly J.M., Karnell L.H., and Menck H.R. National Cancer Data Base report on esophageal carcinoma. Cancer 78 (1996) 1820-1828
38. Herskovic A., Martz K., al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1629-1631
39. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: Long term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 281 (1999) 1623-1627
40. Tepper J.E., Krasna M., Niedzwiecki D., et al. Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781. [Abstract]. J Clin Oncol 24 18S (2006) 4012
41. Swisher S., Winters K., Komaki R., et al. A phase II study of a paclitaxel based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: Initial reporting of RTOG 0246. Int J Radiat Oncol Biol Phys 69 (2007) S106
42. Wilson M, Rosato EL, Chojnacki KA, et al. Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res. Epub 2007 August 28.
43. Wijnhoven B.P.L., Tran K.T.C., Esterman A., et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 245 (2007) 717-725
44. Lagarde S.M., Ten Kate F.J.W., Reitsma J.B., et al. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 24 (2006) 4347-4355
45. Bollschweiler E., Baldus S.E., Schroder W., et al. Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?. J Surg Oncol 94 (2006) 355-363
46. Gaspar L.E., Winter K., Kocha W.I., et al. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group study 9207). Cancer 88 (2000) 988-995